VPCIR Biosciences
VPCIR Biosciences is a spin-out from Aarhus University, Denmark, with 20 years of development in technology capable of detecting living pathogens in saliva. The company is focused on developing faster, cheaper, and non-invasive diagnostic tests, starting with tuberculosis and expanding to other infectious diseases, using innovative lateral flow tests and proprietary technology.
Industries
Nr. of Employees
small (1-50)
Products
Saliva-based lateral flow tuberculosis test (planned availability 2025)
A point-of-care lateral flow test designed to detect active tuberculosis from saliva using enzyme-activity based sensing, intended to be non-invasive and low-cost for field use.
Rolling circle amplification activity kit (research/assay kit)
A laboratory kit/workflow demonstrating RCA-based detection of topoisomerase and other enzyme activities in biological samples for research and assay development.
DNA sensor platform for viral integrase and retrovirus detection
A DNA sensor approach that translates integrase-mediated integration events into RCA templates for highly sensitive detection and discrimination of retroviruses.
Saliva-based lateral flow tuberculosis test (planned availability 2025)
A point-of-care lateral flow test designed to detect active tuberculosis from saliva using enzyme-activity based sensing, intended to be non-invasive and low-cost for field use.
Rolling circle amplification activity kit (research/assay kit)
A laboratory kit/workflow demonstrating RCA-based detection of topoisomerase and other enzyme activities in biological samples for research and assay development.
DNA sensor platform for viral integrase and retrovirus detection
A DNA sensor approach that translates integrase-mediated integration events into RCA templates for highly sensitive detection and discrimination of retroviruses.
Services
Protocol development and on-site execution of field trials comparing enzyme-activity diagnostics to reference molecular tests and monitoring treatment response.
Design and optimization of enzyme-activity based assays with pump-free microfluidic extraction and visual/colorimetric outputs for point-of-care use.
Support for developing QMS and processes aligned with ISO 13485 and IVDR requirements to prepare diagnostics for CE marking and market entry.
Protocol development and on-site execution of field trials comparing enzyme-activity diagnostics to reference molecular tests and monitoring treatment response.
Design and optimization of enzyme-activity based assays with pump-free microfluidic extraction and visual/colorimetric outputs for point-of-care use.
Support for developing QMS and processes aligned with ISO 13485 and IVDR requirements to prepare diagnostics for CE marking and market entry.
Expertise Areas
- Enzyme-activity based diagnostics
- Point-of-care lateral flow diagnostics
- Saliva-based infectious disease testing
- Rolling circle amplification assay development
Key Technologies
- Rolling circle amplification (RCA)
- Lateral flow assays
- Droplet microfluidics
- Molecular beacons (fluorometric probes)
News & Updates
A study conducted from February to September 2023 to evaluate the REEAD technology for TB diagnosis in Oman.
Introduction of a saliva-based malaria diagnostic method using droplet microfluidics and DNA sensors.
A novel assay using droplet microfluidics to detect malaria parasite enzyme activity in blood samples.
A new DNA sensor system employing rolling circle amplification for sensitive and specific detection of retroviruses like HIV.
A novel molecular assay for malaria detection in saliva, utilizing enzyme activity and colorimetric detection.
A sensitive assay based on topoisomerase IA activity for detecting tuberculosis bacteria in small biological samples.
A study conducted from February to September 2023 to evaluate the REEAD technology for TB diagnosis in Oman.
Introduction of a saliva-based malaria diagnostic method using droplet microfluidics and DNA sensors.
A novel assay using droplet microfluidics to detect malaria parasite enzyme activity in blood samples.
A new DNA sensor system employing rolling circle amplification for sensitive and specific detection of retroviruses like HIV.
A novel molecular assay for malaria detection in saliva, utilizing enzyme activity and colorimetric detection.
A sensitive assay based on topoisomerase IA activity for detecting tuberculosis bacteria in small biological samples.